Paulson & Co. Inc.
- SEC CIK
- 0001035674
- Latest filing
- Aug 14, 2026
MDGL holding history
Madrigal Pharmaceuticals, Inc. in every 13F filed by Paulson & Co. Inc., including the quarters it was sold out or no filing was made. Changes compare share counts with the previous calendar quarter.
MDGL overviewAll 13F holders of MDGLFull Q2 2026 holdings
- Shares (Q2 2026)
- 1,340,020
- Value
- $719.5M
- % of portfolio
- 27.9%
- Quarters held
- 13
- Since Q2 2023
| Quarter | Shares | Value | % of portfolio | Share change | Action | All holders |
|---|---|---|---|---|---|---|
| Q2 2026 | 1,340,020 | $719.5M | 27.9% | −52,168−3.7% | Reduced | Holders |
| Q1 2026 | 1,392,188 | $728.8M | 23.4% | −315,334−18.5% | Reduced | Holders |
| Q4 2025 | 1,707,522 | $994.4M | 30.5% | −200,001−10.5% | Reduced | Holders |
| Q3 2025 | 1,907,523 | $874.9M | 29.5% | −182,000−8.7% | Reduced | Holders |
| Q2 2025 | 2,089,523 | $632.4M | 31.4% | −10,000−0.5% | Reduced | Holders |
| Q1 2025 | 2,099,523 | $695.4M | 39.8% | +57,523+2.8% | Added | Holders |
| Q4 2024 | 2,042,000 | $630.1M | 38.1% | 00.0% | Unchanged | Holders |
| Q3 2024 | 2,042,000 | $392.6M | 27.5% | +192,000+10.4% | Added | Holders |
| Q2 2024 | 1,850,000 | $518.3M | 38.3% | +75,000+4.2% | Added | Holders |
| Q1 2024 | 1,775,000 | $474.0M | 32.7% | +669,259+60.5% | Added | Holders |
| Q4 2023 | 1,105,741 | $255.8M | 23.1% | +605,741+121.1% | Added | Holders |
| Q3 2023 | 500,000 | $73.0M | 6.5% | +149,800+42.8% | Added | Holders |
| Q2 2023 | 350,200 | $80.9M | 7.9% | +350,200 | New | Holders |